Vasculitis Flashcards

1
Q

What is primary vasculitis?

A

results from an inflammatory response that targets the vessel walls and has no known cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is secondary vasculitis?

A

may be triggered by an infection, a drug, or a toxin and may occur as part of another inflammatory disorder or cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the aetiology of Takayasu Arteritis?

A
  • Generally occurs < 40 years
  • More common in females
  • More prevalent in Asian populations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the presentation of Takayasu Arteritis?

A
  • Early features include non specific features - low grade fever, malaise, night sweats, weight loss, arthralgia and fatigue
  • Following this - claudication in upper and lower limbs
  • If untreated, vascular stenosis and aneurysms can occur - results in bruit (most commonly carotid), reduced pulses, blood pressure difference of extremities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the investigations for Takayasu Arteritis?

A
  • Bloods - raised inflammatory markers
  • Imaging - MR angiogram can detect thickened vessel walls and stenosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the aetiology of Giant cell arteritis?

A
  • Most common cause of systemic vasculitis in adults
  • Unknown aetiology
  • Generally occurs > 50 years, most commonly late 60+
  • Strong association with polymyalgia rheumatica
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the presentation of giant cell arteritis?

A
  • Symptoms:
    • Unilateral acute temporal headache with focal tenderness on direct palpation
    • Jaw claudication during chewing of firm foods or speaking (caused by ischaemia of the maxillary artery)
    • Visual disturbances e.g. blurring
    • Visual loss (amaurosis fugax)
    • Constitutional manifestations e.g. fatigue, malaise and fever may also be present
  • Signs:
    • Tender enlarged non-pulsatile temporal arteries
  • GCA should always be considered in the differential diagnosis of a new-onset headache in patients 50 years of age or older with an elevated erythrocyte sedimentation rate (ESR), CRP or plasma viscosity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the investigations for giant cell arteritis?

A
  • Bloods - raised inflammatory markers
  • Temporal artery USS (first line)
  • Temporal artery biopsy (gold standard)
    • Transmural inflammation of the intima, media, and adventitia of affected arteries
    • Patchy infiltration by lymphocytes, macrophages, and multinucleated giant cells
    • Vessel wall thickening can result in arterial luminal narrowing, resulting in subsequent distal ischemia
    • A positive temporal artery biopsy has 100% specificity but relatively low sensitivity (15-40%) for the diagnosis of GCA due to the presence of skip lesions - biopsy may be taken from a normal segment
  • PET CT or CT angiogram if other tests inconclusive/negative but high clinical suspicion remains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the management of giant cell arteritis and takayasu arteritis?

A
  • Start at prednisolone 40-60mg daily
  • TA - more long term, use steroid sparing agents if needed e.g. leflunomide, methotrexate
  • GCA - gradual reduction in steroid dose over 18 months - 2 years
    • If patient relapses in early stages of treatment - leflunomide, methotrexate
    • Tocilizumab useful in resistant/relapsing GCA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is granulomatosis with polyangiitis?

A

Granulomatous inflammation affecting small and medium sized vessels in the upper and lower respiratory tract, eyes and/or kidneys (necrotising glomerulonephritis common)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the aetiology of granulomatosis with polyangiitis?

A
  • More common in northern Europeans
  • Slightly higher incidence in males (1.5:1)
  • Typically age 35-55 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the presentation of granulomatosis with polyangiitis?

A
  • Constitutional symptoms and arthralgia common
  • ENT features: sinusitis, nasal crushing, epistaxis, mouth ulcers, sensorineural deafness, otitis media, ‘saddle nose’ (due to cartilage damage from ischaemia), subglottic inflammation
  • Respiratory features: cough, haemoptysis, pulmonary infiltrates, diffuse alveolar haemorrhage, cavitating nodules on CXR
  • Ocular features: conjunctivitis, episcleritis, uveitis, optic nerve vasculitis, retinal artery occlusion, proptosis
  • Cutaneous features: palpable purpura, cutaneous ulcers
  • Renal: necrotising glomerulonephritis
  • Nervous system: mononeuritis multiplex, sensorimotor polyneuropathy, cranial nerve palsies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is eosinophilic granulomatosis with polyangiitis?

A

Eosinophilic granulomatous inflammation affecting small and medium sized vessels most commonly in the respiratory tract and skin, but can also affect the renal, cardiovascular, gastrointestinal, central and peripheral nervous system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the presentation of eosinophilic granulomatosis with polyangiitis?

A

Many features similar to GPA, main difference is late onset asthma, high eosinophil count and ANCA specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is microscopic polyangiitis?

A

Necrotising vasculitis of small vessels with few immune deposits, typically with pulmonary, renal and skin involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the presentation of microscopic polyangiitis?

A

Necrotising glomerulonephritis very common - occurs in up to 90% of patients

17
Q

What are the investigations for small vessel vasculitis?

A

Bloods

  • ESR, PV and CRP raised
  • Anaemia common in chronic disease
  • U+E for renal involvement
  • Complement is consumed during active disease - C3/C4 may fall

Immunofluorescence

  • Anti-neutrophil cytoplasmic antibodies (ANCAs): auto-antibodies against antigens in the cytoplasm of neutrophil granulocytes
  • ANCA, anti-PR3 and anti-MPO levels can vary with disease activity
  • ANCA is negative in a proportion of all these conditions so it cannot be relied upon to confirm the diagnosis

Biopsy

  • Of affected area to confirm
18
Q

What is the management of small vessel vasculitis?

A
  • Depends on level of disease involvement
  • Most cases require treatment with IV steroids and cyclophosphamide due to their aggressive disease course
19
Q

What is Henoch-Schonlein purpura?

A

IgA-mediated generalised vasculitis involving small vessels of the skin, GI tract, kidneys, joints, rarely the lungs and CNS

20
Q

What is the aetiology of henoch-schonlein purpura?

A
  • 75% of cases occur in children age 2-11, rare in infants
  • 75% of patients have had a preceding infection (URTI, pharyngeal, GI), most commonly GAS, 1-3 weeks before HSP develops
21
Q

What is the presentation of Henoch-Schonlein Purpura?

A
  • Purpuric rash typically over buttocks and lower limbs
  • Colicky abdominal pain
  • Bloody diarrhoea
  • Joint pain +/- swelling
  • Renal involvement (50%)
22
Q

What are the investigations for Henoch-Schonlein purpura?

A
  • Clinical diagnosis but other tests may be useful if uncertainty
    • Bloods:
      • FBC, U+Es, LFTs, inflammatory markers, complement levels
      • ANCAs and specific antibodies
      • Connective tissue disease screen
    • Imaging - CXR and/or CT scan
    • Nerve conduction tests
    • Tissue biopsy for definitive diagnosis in uncertain cases
  • Urine dipstick should always be performed to check for renal involvement
23
Q

What is the management of Henoch-Schonlein purpura?

A
  • Usually self-limiting within 8 weeks, may be relapses (months-years after resolution)
  • Urinalysis and BP should be closely monitored during course of illness due to risk of renal failure - may require nephrology referral
24
Q

What is polymyalgia rheumatica?

A

Relatively common chronic inflammatory condition of unknown aetiology that affects elderly individuals

25
Q

What is the aetiology of polymyalgia rheumatica?

A
  • Occurs almost exclusively in patients > 50 years
  • Incidence higher in northern regions
  • Associated with giant cell arteritis
    • Approximately 15% of patients with PMR develop giant cell arteritis (GCA), and 40-50% of patients with GCA have associated PMR
26
Q

What is the presentation of polymyalgia rheumatica?

A
  • Proximal myalgia of the hip and shoulder girdles with accompanying morning stiffness that lasts for at least 45 mins
    • Usually symmetrical
    • Usually occurs relatively quickly - stiffness develops over a few weeks
    • Pain is worse with movement
  • Systemic symptoms such as fatigue, anorexia, weight loss and fever may occur
  • Reduced movement of shoulders, neck and hips
  • Muscle strength is normal
  • Upper arm tenderness
  • Carpal tunnel syndrome
  • Pitting oedema
27
Q

What are the investigations of polymyalgia rheumatica?

A
  • Mainly clinical diagnosis
  • Bloods - raised inflammatory markers
28
Q

What is the management of polymyalgia rheumatica?

A
  • Rapid and dramatic response to low dose steroids
  • Start at prednisolone 15mg daily
  • Gradual reduction in steroid dose over 18 months to 2 years
    • By the end of this period the condition will have resolved in the majority of cases